Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 4, 2016

View Archived Issues

Launch of Carrick Therapeutics

Verastem and Merck & Co. to collaborate with Cancer Research UK for cancer immunotherapy research

CohBar advances two drug candidates into IND-enabling activities

Japanese phase III trial of AJG-533 for chronic constipation meets primary endpoint

MMV and Zydus Cadila collaborate on new antimalarial

Depletion-free 3D LC/MS quantitative proteomics pilot study identifies prostate cancer biomarkers

Self-restricted CRISPR system reduces off-target effects while maintaining viral vector advantages

CTHRC1 blockade inhibits primary tumorigenesis and metastasis in pancreatic cancer

Inhibition of MASP-2 improves neurological and histopathological outcomes post-ischemic brain injury

RANKL inhibition as a promising therapeutic strategy to reduce breast cancer recurrence

First patient dosed in phase I/II trial of CK-101

Bayer Pharma patents factor XIa inhibitors

Aralez Pharmaceuticals announces availability of Yosprala antiplatelet therapy

Oncodesign discloses ALK-1 and/or ALK-2 inhibitors

Zurampic 200 mg tablets now available in U.S. for patients with uncontrolled gout

EMA accepts for review MAA for Herceptin biosimilar SB-3

European Commission approves transfer of marketing authorization for eftrenonacog alfa

Eli Lilly describes BACE1 inhibitors

Contract between BARDA and Emergent Biosolutions will support advancement of anthrax vaccine

FDA grants breakthrough therapy designation to Alecensa for first-line ALK-positive NSCLC

Korea University Research and Business Foundation develops TSLP ligands

Calitor Sciences and Sunshine Lake Pharma present PI3K inhibitors

Jazz Pharmaceuticals initiates rolling submission of NDA for Vyxeos

Once-daily Belviq XR available in U.S. for chronic weight management

EUCLID trial of Brilinta in peripheral artery disease does not meet primary endpoint

Teva Pharmaceuticals acquires Anda

Adrenomedullin may be involved in the pathogenesis of bone cancer and neuropathic pain

TRAP5b shows promise as a prognostic biomarker in osteoarthritis

Nobel Prize in medicine awarded to Yoshinori Ohsumi for work on autophagy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...